Sensible Biotechnologies
A platform for designing and manufacturing naturally modified mRNA medicines.
$47MSeries A
ParticipantActivity from announced rounds
A platform for designing and manufacturing naturally modified mRNA medicines.
Develops human-derived antibody therapeutics for atopic dermatitis and inflammatory disease
Develops cell therapies using proprietary Cellgorithm platform for regenerative medicine